160 related articles for article (PubMed ID: 36670189)
1. Selective deficiency of UCP-1 and adropin may lead to different subtypes of anti-neutrophil cytoplasmic antibody-associated vasculitis.
Chen Q; Li Y; Guo X; Liu Y; Guo Y; Lv X; Lin Y; Liu Q
Genes Immun; 2023 Feb; 24(1):39-45. PubMed ID: 36670189
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
Kim SM; Choi SY; Kim SY; Kim J
Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
[TBL] [Abstract][Full Text] [Related]
3. Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis.
Hakroush S; Tampe D; Ströbel P; Korsten P; Tampe B
Front Immunol; 2021; 12():737708. PubMed ID: 34759920
[TBL] [Abstract][Full Text] [Related]
4. Lessons from a double-transgenic neutrophil approach to induce antiproteinase 3 antibody-mediated vasculitis in mice.
Schreiber A; Eulenberg-Gustavus C; Bergmann A; Jerke U; Kettritz R
J Leukoc Biol; 2016 Dec; 100(6):1443-1452. PubMed ID: 27365530
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
[TBL] [Abstract][Full Text] [Related]
6. Protective α1-antitrypsin effects in autoimmune vasculitis are compromised by methionine oxidation.
Ebert M; Jerke U; Eulenberg-Gustavus C; Kling L; Jenne D; Kirchner M; Mertins P; Bieringer M; Elitok S; Eckardt KU; Schreiber A; Salama AD; Kettritz R
J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36125911
[TBL] [Abstract][Full Text] [Related]
7. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
Mohammad AJ; Segelmark M
J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
[TBL] [Abstract][Full Text] [Related]
8. CX3CL1-induced CD16
Tang J; Liao Z; Luo L; Deng S; Jiang Y; Wang F; Hu X; Yin H; Gong G; Feng J; Li X
Front Immunol; 2022; 13():929244. PubMed ID: 36059489
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
Bornstein G; Ben-Zvi I; Furie N; Grossman C
Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
[TBL] [Abstract][Full Text] [Related]
10. An unusual presentation of propylthiouracil-induced anti-MPO and PR3 positive ANCA vasculitis with associated anti-GBM antibodies, IgA nephropathy and an IgG4 interstitial infiltrate: a case report.
Galante JR; Daruwalla CP; Roberts ISD; Haynes R; Storey BC; Bottomley MJ
BMC Nephrol; 2020 Jul; 21(1):295. PubMed ID: 32703233
[TBL] [Abstract][Full Text] [Related]
11. Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
Murosaki T; Sato T; Akiyama Y; Nagatani K; Minota S
Mod Rheumatol; 2017 Jan; 27(1):95-101. PubMed ID: 27320904
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Harper L; Cockwell P; Adu D; Savage CO
Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
[TBL] [Abstract][Full Text] [Related]
13. New advances in the pathogenesis of ANCA-associated vasculitides.
Chen M; Kallenberg CG
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
[TBL] [Abstract][Full Text] [Related]
14. [The significances of peripheral neutrophils CD(55) and myeloperoxidase expression in patients with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody associated vasculitis].
Zhou XL; Zheng MJ; Shuai ZW; Zhang L; Zhang MM; Chen SY
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):427-432. PubMed ID: 28592042
[No Abstract] [Full Text] [Related]
15. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
Csernok E; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
[TBL] [Abstract][Full Text] [Related]
16. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
18. Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.
Hilhorst M; van Paassen P; Tervaert JW;
J Am Soc Nephrol; 2015 Oct; 26(10):2314-27. PubMed ID: 25956510
[TBL] [Abstract][Full Text] [Related]
19. Distinct HLA and non-HLA associations in different subtypes of ANCA-associated vasculitides in North India.
Singh J; Sharma A; Rani L; Kaur N; Anand S; Saikia B; Jha S; Nada R; Minz RW
Int J Rheum Dis; 2020 Jul; 23(7):958-965. PubMed ID: 32297471
[TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.
Rao DA; Wei K; Merola JF; O'Brien WR; Takvorian SU; Dellaripa PF; Schur PH
J Rheumatol; 2015 May; 42(5):847-52. PubMed ID: 25834211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]